ChenGuang Biotech Group Co., Ltd. (300138.SZ)
CNY 11.08
(-8.05%)
CNY 11.08
(-8.05%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 249.59 Million CNY | -30.16% |
| 2022 | 370.51 Million CNY | 27.57% |
| 2021 | 290.43 Million CNY | 14.21% |
| 2020 | 254.29 Million CNY | -20.23% |
| 2019 | 318.81 Million CNY | 28.5% |
| 2018 | 248.09 Million CNY | 34.05% |
| 2017 | 185.08 Million CNY | -6.97% |
| 2016 | 198.94 Million CNY | 81.17% |
| 2015 | 109.8 Million CNY | 12.85% |
| 2014 | 97.3 Million CNY | -9.71% |
| 2013 | 107.77 Million CNY | 5.86% |
| 2012 | 101.8 Million CNY | 39.65% |
| 2011 | 72.9 Million CNY | 57.99% |
| 2010 | 46.14 Million CNY | 19.08% |
| 2009 | 38.75 Million CNY | 60.79% |
| 2008 | 24.1 Million CNY | 61.04% |
| 2007 | 14.96 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 70.01 Million CNY | -5.44% |
| 2024 Q1 | 74.04 Million CNY | -16.84% |
| 2024 Q3 | 53.06 Million CNY | 105.38% |
| 2023 Q4 | 89.04 Million CNY | 19.68% |
| 2023 FY | 258.78 Million CNY | -30.16% |
| 2023 Q1 | 66.82 Million CNY | -25.79% |
| 2023 Q2 | 60.62 Million CNY | -9.28% |
| 2023 Q3 | 74.39 Million CNY | 22.72% |
| 2022 Q2 | 95.1 Million CNY | 27.48% |
| 2022 Q3 | 110.74 Million CNY | 16.45% |
| 2022 Q4 | 90.05 Million CNY | -18.69% |
| 2022 FY | 370.51 Million CNY | 27.57% |
| 2022 Q1 | 74.6 Million CNY | -25.58% |
| 2021 Q4 | 100.24 Million CNY | 23.11% |
| 2021 FY | 290.43 Million CNY | 14.21% |
| 2021 Q1 | 52.03 Million CNY | 435.86% |
| 2021 Q2 | 56.72 Million CNY | 9.02% |
| 2021 Q3 | 81.42 Million CNY | 43.54% |
| 2020 Q2 | 90 Million CNY | 12.54% |
| 2020 Q1 | 79.97 Million CNY | -4.48% |
| 2020 Q3 | 99.82 Million CNY | 10.91% |
| 2020 FY | 254.29 Million CNY | -20.23% |
| 2020 Q4 | -15.49 Million CNY | -115.52% |
| 2019 Q3 | 82.45 Million CNY | -3.31% |
| 2019 FY | 318.81 Million CNY | 28.5% |
| 2019 Q1 | 67.35 Million CNY | -19.77% |
| 2019 Q2 | 85.27 Million CNY | 26.61% |
| 2019 Q4 | 83.71 Million CNY | 1.53% |
| 2018 FY | 248.09 Million CNY | 34.05% |
| 2018 Q4 | 83.95 Million CNY | 38.67% |
| 2018 Q3 | 60.54 Million CNY | 11.92% |
| 2018 Q2 | 54.09 Million CNY | 9.27% |
| 2018 Q1 | 49.5 Million CNY | 6.5% |
| 2017 Q4 | 46.48 Million CNY | 2.46% |
| 2017 Q2 | 39.59 Million CNY | -26.18% |
| 2017 Q1 | 53.63 Million CNY | -32.91% |
| 2017 FY | 185.08 Million CNY | -6.97% |
| 2017 Q3 | 45.36 Million CNY | 14.58% |
| 2016 Q3 | 43.94 Million CNY | 6.29% |
| 2016 FY | 198.94 Million CNY | 81.17% |
| 2016 Q1 | 33.7 Million CNY | -2.33% |
| 2016 Q2 | 41.34 Million CNY | 22.69% |
| 2016 Q4 | 79.94 Million CNY | 81.92% |
| 2015 Q1 | 24.25 Million CNY | -15.43% |
| 2015 FY | 109.8 Million CNY | 12.85% |
| 2015 Q2 | 26.73 Million CNY | 10.23% |
| 2015 Q3 | 24.3 Million CNY | -9.1% |
| 2015 Q4 | 34.5 Million CNY | 41.96% |
| 2014 Q3 | 21.83 Million CNY | -13.05% |
| 2014 Q4 | 28.68 Million CNY | 31.34% |
| 2014 FY | 97.3 Million CNY | -9.71% |
| 2014 Q1 | 21.67 Million CNY | -7.11% |
| 2014 Q2 | 25.11 Million CNY | 15.88% |
| 2013 Q4 | 23.33 Million CNY | -2.96% |
| 2013 Q2 | 34.67 Million CNY | 34.77% |
| 2013 Q1 | 25.72 Million CNY | 56.64% |
| 2013 FY | 107.77 Million CNY | 5.86% |
| 2013 Q3 | 24.04 Million CNY | -30.66% |
| 2012 Q3 | 32.54 Million CNY | 6.99% |
| 2012 Q1 | 22.42 Million CNY | 6.99% |
| 2012 Q4 | 16.42 Million CNY | -49.53% |
| 2012 FY | 101.8 Million CNY | 39.65% |
| 2012 Q2 | 30.41 Million CNY | 35.64% |
| 2011 Q1 | 15.56 Million CNY | 26.63% |
| 2011 FY | 72.9 Million CNY | 57.99% |
| 2011 Q4 | 20.95 Million CNY | 7.26% |
| 2011 Q3 | 19.54 Million CNY | 16.05% |
| 2011 Q2 | 16.83 Million CNY | 8.17% |
| 2010 FY | 46.14 Million CNY | 19.08% |
| 2010 Q2 | 10.17 Million CNY | -9.4% |
| 2010 Q3 | 12.45 Million CNY | 22.41% |
| 2010 Q4 | 12.29 Million CNY | -1.29% |
| 2010 Q1 | 11.22 Million CNY | 17.71% |
| 2009 FY | 38.75 Million CNY | 60.79% |
| 2009 Q3 | 12.27 Million CNY | 0.0% |
| 2009 Q4 | 9.53 Million CNY | -22.25% |
| 2008 FY | 24.1 Million CNY | 61.04% |
| 2007 FY | 14.96 Million CNY | 0.0% |